We are live on
!
Find out more
ALXN
Alexion Pharmaceuticals
ALXN
ALXN
Delisted
ALXN was delisted on the 20th of July, 2021.
752 hedge funds and large institutions have $31.3B invested in Alexion Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 83 funds opening new positions, 244 increasing their positions, 313 reducing their positions, and 149 closing their positions.
New
Increased
Maintained
Reduced
Closed
52% more funds holding in top 10
Funds holding in top 10: 46 → 70 (+24)
0% less capital invested
Capital invested by funds: $31.3B → $31.3B (-$29.8M)
9% less funds holding
Funds holding: 824 → 752 (-72)
22% less repeat investments, than reductions
Existing positions increased: 244 | Existing positions reduced: 313
24% less call options, than puts
Call options by funds: $202M | Put options by funds: $267M
44% less first-time investments, than exits
New positions opened: 83 | Existing positions closed: 149
Holders
752
Holders Change
-72
Holders Change %
-8.74%
% of All Funds
13.2%
Holding in Top 10
70
Holding in Top 10 Change
+24
Holding in Top 10 Change %
+52.17%
% of All Funds
1.23%
New
83
Increased
244
Reduced
313
Closed
149
Calls
$202M
Puts
$267M
Net Calls
-$64.3M
Net Calls Change
-$187M
Top Buyers
| 1 |
HI
HBK Investments
Dallas,
Texas
|
+$619M |
| 2 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$546M |
| 3 |
DKCM
Davidson Kempner Capital Management
New York
|
+$533M |
| 4 |
Barclays
London,
United Kingdom
|
+$497M |
| 5 |
Citigroup
New York
|
+$334M |
Top Sellers
| 1 |
ClearBridge Investments
New York
|
-$917M |
| 2 |
BBA
Baker Bros. Advisors
New York
|
-$737M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$426M |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$318M |
| 5 |
JP Morgan Chase
New York
|
-$317M |
